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Abstract 
The wheat monomeric inhibitor WMAI-1 (syn. 0.28) produced in Escherichia coli using the pT7-7 ex-
pression vector has the correct N-terminal sequence and the same electrophoretic mobility and specific 
activity towards the a-amylase from the insect Tenebrio molitor as the native WMAI-1 isolated from 
wheat. This confirms that the native inhibitor is not glycosylated and contradicts claims that a putative 
glycosyl moiety was essential for inhibition. Thirteen mutants have been obtained at six different sites. 
Substitution of the highly conserved N-terminal S by the sequence ARIRAR increased the pre-incubation 
time required for máximum activity. A similar result was obtained by insertion of GPRLPW after po-
sition 4, while insertion of EPRAPW at the same position rendered the inhibitor inactive. The substi-
tution D/EGPRL and insertions D G P or D, at position 58, produced complete inactivation. All other 
mutations had only minor effects on activity. 
Introduction 
A single protein family from cereals includes tryp-
sin inhibitors and monomeric, dimeric, and tet-
rameric inhibitors of heterologous a-amylases 
[4, 5]. These inhibitors, which are quite abundant 
in endosperm, are of interest because of their pos-
sible role as plant defence proteins [4, 5, 7, 10, 16, 
18] and because they are major allergens involved 
in baker's asthma disease [1, 8, 22]. Although 
there is considerable information concerning the 
reactive sites and other relevant features of pro-
tease inhibitors (see [4]) little is known about the 
key structural details responsible for a-amylase 
inhibition. 
The wheat monomeric a-amylase inhibitor 
WMAI-1 (syn. 0.28) is among the best charac-
terized members of this family. It is highly active 
against the a-amylase of the insect Tenebrio 
molitor and has little activity against the human 
salivary a-amylase [4, 15]. Its amino acid se-
quence has been determined by direct protein se-
quencing [12, 22] and the existence of five disul-
phide bridges has been inferred [15, 22]. It has 
been claimed that it is a glycoprotein with one 
reducing sugar per molecule [15, 18] and that this 
sugar plays an important role in the inhibition 
mechanism, which involves the interaction of two 
molecules of inhibitor with one molecule of en-
zyme [19]. Failure to confirm the glycoprotein 
nature of this inhibitor by standard biochemical 
methods (G. Salcedo, R. Sanchez-Monge and 
L. Gómez, unpublished) has led to the experi-
ments reported here, which involve the produc-
tion of active inhibitor by expression of its cDNA 
in Escherichia coli and the identification of parts 
of the molecule that are critical for the inhibition 
by site-directed mutagenesis. 
Materials and methods 
Construction of a WMAI-1 expression plasmid 
A cDNA encoding WMAI-1 cloned in the Sma I 
site of plasmid pUC12 (clone pUP28) was pro-
vided by C. Maraña. Expression vector pT7-7 
[21] was the gift of S. Tabor (Boston, MA). An 
expression plasmid was constructed by sub-
cloning a Sty l/Bam HI fragment from plasmid 
pUP28 together with a synthetic Nde I /Sty I 
adaptor oligonucleotide in the Nde 1/BamHl sites 
of plasmid pT7-7 (Fig. 1A). 
Mutagenesis of WMAI-1 
Mutant Al was generated by subcloning of a 
Bst Xl/Pst I fragment from plasmid pUP28, made 
blunt at the Bst XI end, into the Sma l/Pst I sites 
of the pT7-7 polylinker (Figs. 1A and 2A). 
Mutants C were obtained by oligonucleotide-
directed mutagenesis (Amersham kit RPN1523), 
using 43-mer synthetic oligonucleotide I: 
C 
TCGGGCACCTGACTCAGAGGGGGCCC-
A 
GATGCCCACAGACTGGA. 
Mutants B, D, E, and F were constructed using 
the WMAI-1 expression plasmid as parental ma-
terial. Following cleavage with the indicated en-
zyme (Fig. 2A), the linear plasmids were made 
blunt by filling with Klenow (mutants B, D, and 
E) or by recessing with T4 polymerase (mu-
tants F), and ligated in the presence of the cor-
responding double-stranded linker molecule: II, 
G G G C C C G A G G C T C C (both orientations; mu-
tants Bl , B2, DI and D2); III, G G G C C C G A G -
GCTC (in mutants E and F). Linker III intro-
duced a frame shift, so the in-frame mutants 
recovered were spontaneous rearrangements in 
which the reading frame had been restored. A 
first screening of the recombinants (except Al 
and E3) was made by checking the creation of an 
Apa I site. Putative recombinants were further 
checked for the expression of the recombinant 
proteins and then by sequencing. The Sanger 
method [16] was used either after subcloning in 
M13 or directly in the expression plasmid, using 
a primer for the T7 RNA polymerase promoter 
(Boehringer). In two cases, E2 and F l , incorpo-
ration of partial linkers occurred. In mutant E l , 
the correct reading frame was maintained because 
of the deletion of C, likely due to residual 3 ' - 5 ' 
exonuclease activity in the Klenow fragment 
preparation. 
Expression and purifica tion of proteins 
Transformation with the different plasmids was 
carried out in E. coli HMS174 (gift of T. Ruiz-
Argüeso, Madrid) to avoid instability problems. 
E. coli BL21 (DE3), which contains a lac-
inducible RNA-polymerase gene, was used for 
*protein expression. 
Cultures grown at 37 °C to A 6 6 0 » 0.4-0.5, in-
duced with isopentenylthiogalactoside (IPTG) for 
2-4 h, centrifuged, resuspended in buffer (10 juM 
Tris-HCl, pH 7.5, 20% w/v sucrose, 15 mM 
EDTA) and incubated on ice for 30 min. Cells 
were harvested, resuspended in distilled water 
and sonicated. A cytosolic frac tion and a pellet 
containing inclusión bodies were obtained by 
centrifugation at 15000 x g for 20 min. Inclusión 
bodies were washed with buffer A (50 mM Tris-
HCl pH 7.5, 5% glycerol) containing 2 M NaCl 
and extracted with 2 M guanidinium chloride in 
the same buffer. After dialysis against buffer A 
with 1 M NaCl, the extracted proteins were pre-
cipitated with 70% ( N H 4 ) 2 S 0 4 and resuspended 
in 0.1 M acetic acid, dialysed and freeze-dried. 
Final purification was achieved by reversed-phase 
high-performance liquid chromatography (RP-
HPLC) on an Ultrapore RPSC C3 column (par-
ticle size 5 ¡.im\ 1 cm x 25 cm; Beckman) using a 
20-30% linear gradient of acetonitrile in H a O 
containing 0 .1% trifluoroacetic acid. 
Enzyme inhibition tests 
Inhibitory activity against the a-amylase from lar-
vae of Tenebrio molitor was tested using a buffer 
containing 20 mM sodium acétate pH 5.4, 
100 raM NaCl, 0.1 mM CaCl2 as described by 
Gutiérrez et al. [10]. The a-amylase and the in-
hibitor were preincubated at 25 °C for the indi-
cated times. Previously reported methods were 
used to assay trypsin [2.3] and chymotrypsin 
[11]. 
Other methods 
Protein concentrations were determined by the 
method of Smith et al. [20]. Sodium dodecyl sul-
phate polyacrylamide gel electrophoresis (SDS-
PAGE) was performed according to Laemli [13]. 
N-terminal amino acid sequences were performed 
by automated Edman degradation by C. Buesa 
(University of Barcelona). 
Results 
Production of WMAI-1 in Escherichia coli 
The sequence of the insert in plasmid pU28 
(C. Maraña et al, unpublished) encoded a pro-
tein with the same amino acid sequence reported 
for WMAI-1 [12, 22], except for a G D deletion 
after position 114. A Sty l-Bam HI fragment of 
the WMAI-1 cDNA clone was subcloned in the 
pT7-7 plasmid, between the Nde I and Bam HI 
sites, using an Nde l-Sty I adaptor oligonucleotide 
which reconstructed the cDNA sequence coding 
for the N-terminal of the WMAI-1 mature pro-
tein, plus an N-terminal methionine, thus elimi-
nating the signal peptide (Fig. 1A). Cultures of 
E. coli (BL21) transformed with the expression 
plasmid and induced with IPTG showed an extra 
band when analysed by SDS-PAGE that was 
absent in induced cultures containing the plasmid 
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Fig. 1. Expression of WMAI-1 (syn. 0.28) in E. coli. A. In-
sertion of D N A encoding WMAI-1 in expression plasmid 
pT7-7, which contains a promoter for T7 RNA polymerase 
(<p 10) and a ribosome binding site (RBS). B. Expression and 
purification of WMAI-1 . Indicated bacteria containing pT7-
7 with (tracks 2, 4, 6, 7, 8) and without (tracks 1, 3, 5) the 
W M A M insert were fractionated as described in Materials 
and methods: total extract from 125 ul of culture (1, 2); 25 ul 
of cytosolic fraction (3, 4); inclusión bodies equivalent to 125 
ul of cytosolic fraction (5, 6); 15 ug of acetic acid extract (7); 
5 ug of H P L C purified fraction (8); 5 ug of native WMAI-l 
(9). Horizontal arrow points to WMAI-1 band. C. Inhibitory 
activity against the a-amylase of the insect Tenebrio molitor of 
the WMAI-1 produced in E. coli ( • ) and the native one 
isolated from wheat cv. Chinese Spring (O) . Activity is rep-
resented as a percentage of the a-amylase activity obtained 
without inhibitors. 
without insert and had the electrophoretic mobil-
ity of native WMAI-1 (Fig. IB). This protein ac-
cumulated in inclusión bodies, from where it was 
purified by solubilization with 2 M guanidinium 
chloride, precipitation with 70% saturated 
( N H 4 ) 2 S 0 4 , solubilization with 0.1 M acetic acid, 
and fractionation by RP-HPLC (Fig. IB). The 
purified protein and native WMAI-1 from the 
same Chinese Spring wheat cultivar used to clone 
the c D N A had the same specific inhibitory activ-
ity (Fig. 1C). Correct processing of the terminal 
methionine was checked by amino acid N-ter-
minal sequencing. 
Mutants of WMAI-1 
Three regions of WMAI-1 are rather conserved 
among the known monomeric and dimeric 
a-amylase inhibitors, while being quite divergent 
in the other members of the family [5, 9]: the 
N-terminal sequence before the first cysteine at 
position 7; the sequence between the 3rd and the 
4th cysteines (positions 29-42); and a short se-
quence right after the 7th cysteine (position 56). 
The C-terminal half of the molecule is much var-
iable among the different inhibitors [5]. A total of 
13 mutants were obtained at 6 different sites (A 
through F in Fig. 2). Sites A - E were in the con-
served regions, while site F was in a variable one. 
The mutant genes were sequenced and the alter-
ations found with respect to the wild type are 
usted in Fig. 2A. The deduced amino acid se-
quences of the mutants are presented in Fig. 2B: 
mutant Al consisted of a substitution of the ter-
minal serine by a 6 amino acid sequence (AR-
IRAR) derived from the polylinker in pT7 7; mu-
tants at sites C-E are all insertions; and mutants 
at site F involve the substitution of two residues 
by longer variant sequences. The positions of the 
mutation sites with respect to the predicted sec-
ondary structure of the wild type are represented 
in Fig. 2C. 
Mutants were exprés sed in E. coli and purified 
to homogeneity foliowing the same procedure as 
for the wild type. Their electrophoretic mobilities 
in SDS-PAGE are consistent with the changes 
introduced (Fig. 3). 
Inhibitory activities of the mutants 
All mutants were tested against the a-amylase of 
Tenebrio molitor with 40 min of preincubation 
(Fig. 4). Mutants B2, E l , E2, and E3 were com-
pletely inactive under these experimental condi-
tions. while all others retained high levéis of ac-
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Fig. 2. Site-directed mutagenesis of WMAI-1. A. Mutation 
sites and mutant sequences determined by DNA sequencing. 
Mutation strategies and synthetic oligonucleotides used are 
described in Materials and methods. B. Deduced amino acid 
sequences of the mutants. Substitutions are boxed and inser-
tions are indicated by an arrow. C. Mutation sites indicated 
in the predicted secondary structure of WMAI-1 ([6] and 
Microgenie computer program Beckman). . , 
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Fig. 3. Analysis of purified proteins by SDS-PAGE. N, na-
tive WMAI-1 from wheat cv. Chínese Spring; WT, wild-type 
WMAI-1 produced in E. coli; A1-F2, purified proteins from 
mutants. From mutants C l - 3 the last two purification steps 
were ommitted. Gels were stained with Coomassie blue as 
indicated in Materials and methods. 
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Fig. 5. Comparison of inhibitory activity at 10 min and at 40 
min pre-incubation. Amounts of inhibilor used were the fol-
lowing : WT, 2 ug; A l , 4.5 ug; Bl , 6 ug; D I , 5 ug; D2, 10 ug; 
F l , 7 ug; F2, 7.5 ug. Pre-incubation was at 25 CC. 
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Fig. 4. Inhibitory activity of WMAI-1 mutants against the 
oc-amylase from the insect Tenebrio molitor. Activity is repre-
sented as a percentage of the oc-amylase activity in the absence 
of inhibitor. The wild-type (WT) inhibitor produced in E. coli 
was used for comparison. Enzyme and inhibitor were pre-
incubated for 40 min before substrate was added. 
tivity, although always below that of the wild type. 
As is the case with the native inhibitor from wheat, 
the wild type synthesized in E. coli is fully active 
after 10 min preincubation. In this respect, all 
mutants behaved as the wild type, with the ex-
ception of mutants Al and B l , which required at 
least 40 min of preincubation to reach máximum 
activity (Fig. 5). None of the inhibitors was active 
against trypsin or chymotrypsin. 
Discüssion 
The present evidence that WMAI-1 (syn. 0.28) 
synthesized in E. colihas the same electrophoretic 
mobility as the native one isolated from the en-
dosperm of tne same wheat cultivar used for the 
cDNA cloning, as well as the same specific in-
hibitory activity is in line with its failure to react 
with glycoprotein reagents when bound to filters 
(G. Salcedo, R. Sanchez-Monge and L. Gómez, 
unpublished) and directly contradicts previous 
claims that the inhibitor was glycosylated [15, 18] 
and that the sugar moiety played a key rol in the 
inhibition mechanism [19]. 
The mutants obtained allow the identification 
of two regions of the molecule that are critical for 
the inhibition mechanisms: the N-terminal se-
quence before the lst cysteine (sites A and B), 
and site E, which is right after a CRC motif (po-
sitions 54-56) that is conserved throughout the 
family. The roles of the two regions seem to be 
different, since the effect of mutations in the first 
región (Al, Bl ) affect the kinetics of formation of 
the enzyme-inhibitor complex and tend to have a 
modérate effect on inhibitory activity, whereas all 
the mutations at the E site, even a single amino 
acid insertion (E3), render the inhibitor com-
pletely inactive. 
The substitution of the conserved N-terminal 
serine by a highly basic extensión of six amino 
acids (A) had a more modérate effect on optimum 
preincubation time and on inhibitory activity than 
the insertions in mutants Bl and B2, which do 
not affect the conserved SGPW terminal motif. 
These two mutants, which only differed in one 
conservative (L/A) and one non-conservative (G/ 
E) substitution, markedly diverged in their inhib-
itory properties. It seems that the G—>E differ-
ence makes the N-terminal less flexible, which 
would explain the difference in activity between 
the two mutants. The times required by different 
plant proteinaceous inhibitors of a-amylases to 
react with a-amylase and to reach máximum in-
hibition range widely from 5 min to over 3 h and 
have been considered too long for a diffusion-
controlled reaction between two proteins [18]. 
For this reason, an inhibitor-induced conforma-
tional change has been suggested as the rate-
controlling step in the complexation (see [ 18]). In 
this context, the behaviour of mutants A l , B l , 
and B2 would indicate that the N-terminal of the 
inhibitor plays a role in the postulated conforma-
tional change and is less critical to the stability of 
the enzyme-inhibitor complex, for which the re-
gión around site E would be rather stringently 
critical. 
The loop between the 3rd and 4th cysteines, 
which is quite conserved among the monomeric 
and dimeric a-amylase inhibitors, is also where 
the reactive site (GPRL) of those members of the 
family that inhibit trypsin is present. Mutations at 
two sites (C and D) within this loop had only a 
modérate effect on inhibitory activity. The intro-
duction of the GPRL motif at these or at other 
sites did not lead to trypsin inhibition, indicating 
that other structural differences between mem-
bers of the same family must be critical for this 
inhibitory activity. 
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